CompanyDrug

AbbVie Submits First BLA for c-Met Targeting ADC Telisotuzumab Vedotin to FDA

CompanyDeals

Whittilong Pharma Secures Over RMB 100 Million in Series B Financing for Modified Drug Development

Company

HOYA Surgical Optics Expands in China with New Artificial Intraocular Lens Facility

CompanyDeals

Shanghai Pharmaceuticals Partners with SIBPT to Boost Biopharmaceutical R&D and Translation

CompanyDrug

Shanghai Fosun Pharmaceutical Gets NMPA Clinical Clearance for Lymphoma Drug XS-04

CompanyDrug

Shanghai Fosun Pharmaceutical’s SBK010 Stroke Treatment Accepted for NMPA Review

Company

3D Medicines’ H1’24 Financials Reflect Increased Comprehensive Loss Amid Revenue Decline

Policy / Regulatory

China Sets New Management Measures for Investigator-Initiated Trials in Medical Institutions

Policy / Regulatory

China Unveils Medical Insurance Eligibility Management System for Designated Healthcare Personnel

CompanyDeals

OrbusNeich Medical Group Partners with Abbott’s CSI as Sole Distributor

CompanyDrug

Jacobio Pharma Receives NMPA Approval for Pan-KRAS Inhibitor JAB-23E73 Clinical Trial

CompanyDrug

AstraZeneca’s Tagrisso Secures FDA Approval for Unresectable Stage III EGFRm NSCLC